• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • NMPA Approves Supplementary Testing Methods for Medical Dressing Patches

NMPA Approves Supplementary Testing Methods for Medical Dressing Patches

Saturday, 26 February 2022 / Published in Medical Device, News, NMPA Registration in China

NMPA Approves Supplementary Testing Methods for Medical Dressing Patches

On January 26, 2022, the NMPA (National Medical Products Administration) approved (No.12-2022) the supplementary testing methods proposed by the Shandong Institute of Medical Device and Pharmaceutical Packaging Inspection to identify 17 chemical drugs in medical dressing patches.

According to the Shandong Institute of Medical Device and Pharmaceutical Packaging Inspection, manufacturers have illegally added drugs in dressing products in recent years to demonstrate a prominent therapeutic effect. Without carrying out safety evaluation on the product nor indicating the respective drug ingredients in the packaging, consumers are exposed to risks such as skin allergies and skin irritation.

Scope – Medical Dressing Patches

  • Only applicable to medical dressing patches with functions of physical warming, physical cooling, acupoint pressure stimulation or utilizing magnetic energy such as far-infrared therapeutic patches, medical cold compress patches, medical antipyretic patches, cold compress gel, magnetotherapy patches, acupuncture point pressing and stimulation stickers, etc.
  • Not applicable to thermal therapy stickers and thermal moxibustion stickers that utilize iron powder oxidation and heating as the working principle.

Previously, liquid and paste dressings can be classified as class I, II and III depending on the intended use, application method, etc. However, non-sterile liquid and paste dressings will no longer be classified as a class I medical device as seen removed from the new class I medical device catalogue (No.158 – 2021) which came into effect on January 1, 2022. (More information available in our previous blog post.)

By Julie Zhang and Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: Dressings, Medical Dressing Patches

What you can read next

New Clinical Trial Exemption List
Changes of Health Food Functions Claims
2022 sampling inspection plan
Regulatory Updates Concerning QMS Annual Self-Inspection Reports

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.